Vireo Growth (VREOF) Gross Profit (QoQ) (2020 - 2026)
Vireo Growth (VREOF) Gross Profit (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.69 Bn | 87.82 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.60 Bn | 30.66 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.53 Bn | 23.47 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.06 Bn | 20.91 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - |
| 7 | Viatris | 20.32 Bn | 18.52 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.47 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Vireo Growth | 10.51 Bn | 10.36 Bn | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.25% |
| Dec 31, 2025 | 52.16% |
| Sep 30, 2025 | 83.09% |
| Jun 30, 2025 | 64.66% |
| Mar 31, 2025 | -1.99% |
| Dec 31, 2024 | 2.66% |
| Sep 30, 2024 | -9.05% |
| Jun 30, 2024 | 10.67% |
| Mar 31, 2024 | 1.57% |
| Dec 31, 2023 | -8.65% |
| Sep 30, 2023 | 41.43% |
| Jun 30, 2023 | -1.98% |
| Mar 31, 2023 | 11.80% |
| Dec 31, 2022 | -10.71% |
| Sep 30, 2022 | -8.01% |
| Jun 30, 2022 | 316.57% |
| Mar 31, 2022 | 15.49% |
| Dec 31, 2021 | -57.87% |
| Sep 30, 2021 | -26.01% |
| Jun 30, 2021 | 23.10% |